Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra.
about
HIV-1 and IL-1β regulate astrocytic CD38 through mitogen-activated protein kinases and nuclear factor-κB signaling mechanismsSrc homology-2 domain-containing protein tyrosine phosphatase (SHP) 2 and p38 regulate the expression of chemokine CXCL8 in human astrocytesPathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric DisordersNeuroinflammation in Parkinson's disease and its potential as therapeutic targetInsights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based TherapiesRelevance of chronic stress and the two faces of microglia in Parkinson's diseasePivotal roles of GM-CSF in autoimmunity and inflammationInflammasomes: mechanism of action, role in disease, and therapeuticsNeuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunityInterleukin-1β protects astrocytes against oxidant-induced injury via an NF-κB-dependent upregulation of glutathione synthesis.Neurodegenerative Diseases: Might Citrus Flavonoids Play a Protective Role?Mechanisms of long-term cognitive dysfunction of sepsis: from blood-borne leukocytes to glial cellsIncreased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice.Evidence of inflammatory system involvement in Parkinson's disease.Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.Extracellular regulated kinase 1/2 signaling is a critical regulator of interleukin-1β-mediated astrocyte tissue inhibitor of metalloproteinase-1 expression.CCAAT/enhancer binding protein β expression is increased in the brain during HIV-1-infection and contributes to regulation of astrocyte tissue inhibitor of metalloproteinase-1.Pleiotrophin over-expression provides trophic support to dopaminergic neurons in parkinsonian ratsInterleukin-1β in Central Nervous System Injury and Repair.Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease.Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic interventionExogenous corticosterone reduces L-DOPA-induced dyskinesia in the hemi-parkinsonian rat: role for interleukin-1beta.Non-cell-autonomous Neurotoxicity of α-synuclein Through Microglial Toll-like Receptor 2The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective.4-Hydroxy TEMPO attenuates dichlorvos induced microglial activation and apoptosisActivated immune cells in Parkinson's disease.Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson's disease incidence.Imaging of microglia in patients with neurodegenerative disorders.Modulating microglia activity with PPAR-γ agonists: a promising therapy for Parkinson's disease?Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson's Disease?IL-1Ra and its delivery strategies: inserting the association in perspective.Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches.T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases.The role of neuroinflammation in dementias.The prion hypothesis of Parkinson's disease.Identification of key genes and pathways in Parkinson's disease through integrated analysis.Protein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyond.Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide.Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases.Astrocytes: inexplicable cells in neurodegeneration.
P2860
Q24294630-5D686F96-5225-403F-8804-538D680F1BE6Q24300097-D36E65FC-6F46-45DC-A8B1-62567A324804Q26745690-A51D7997-65F1-4600-B14C-AF9994C9E25AQ26783305-3D6843E9-6CE0-4843-8857-E202DD43D294Q26795984-3B03735B-A5F6-47DD-BB7F-FCBF05B61BC8Q26796241-EE599992-EEB0-4223-9688-AA25FB182976Q26830824-EA51914B-FD2B-4A38-AF7F-96BE91E5F742Q27001186-EDAB5415-B692-4221-B883-ED3E302A2D38Q27027973-33C3AE16-3CA0-4556-8AC4-465EAA8648CAQ27335319-2FBCEEB7-C98A-42EB-9A07-A378CDAFACF3Q28076243-DAB0395F-45C8-4B20-AD12-ED3F89E60418Q28392580-309F00F6-AB33-47F1-8913-E3A9131EC182Q33797938-ED5E3204-E1E0-4A11-98B3-84A778F2CCC8Q33890818-B15B867D-9057-4363-B36C-E6D2CE4EE21DQ34576478-79D8AE74-B565-486B-AF41-66AC849E4557Q34607184-B023F042-70AD-4C3E-BF8A-1ED3B9F60DE4Q35038078-32C1BD26-0C0C-43D1-B532-1CB7EF278402Q35089226-A9A00A66-3548-465E-B981-08FFBDE5C4FEQ35737149-14F3E5D8-8562-4FBE-A916-D582C4527628Q36741828-60E83D60-2EC3-461A-861A-AC56F62C973DQ36919403-EF9D5FCA-F26F-41F3-ACBA-A2BCEE62CD44Q37040535-C1961C13-5C26-4214-B032-F731A8E60212Q37043549-95E1310F-2E09-404A-9760-D68A2BBFF889Q37095615-8C7BFE07-6B51-4F3D-8B56-CE7CDC50225BQ37596215-A4FA799F-4011-4141-8162-ECFD14574E75Q37873407-71CA2A23-F478-406A-8474-B4E71BF90977Q37878282-6AD02A4A-BECD-4A02-B46A-FFAED0C7AD89Q38015834-86625779-DC18-401E-9BBE-557C91DD6BA2Q38032481-2CDC8299-9D59-40AB-91FD-EDC7B3130AC0Q38103856-D2B8E70E-55DD-4461-9D00-3639EF875CB1Q38116457-7FF3197A-CB3B-4B99-A1ED-82CD0FC632DEQ38209311-531D56F3-5AD3-4FF2-9F28-354E514D5E58Q38274179-522E1619-1871-49C8-8FFE-38E80A4DE627Q38365247-80D66594-F105-4A94-999D-BBA51D9BEB55Q38418624-B51E103A-13D5-41F5-B7EA-B6430E9B454DQ38430423-CCA9B9DC-1813-4777-BE1A-ABD7F8142EE7Q38494648-8A1EFB93-EFC4-4407-8C0D-87B2ED56A6B1Q38617000-39A1C8C9-CA2F-44FC-9D36-6CF2A34BC70DQ38715276-08C6556B-F70C-4D1B-8494-721F2855BBF1Q38795492-B45D48A4-0CC8-489A-91E5-8F4D708D09A6
P2860
Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Progressive neurodegeneration ...... 1beta in the substantia nigra.
@en
Progressive neurodegeneration ...... 1beta in the substantia nigra.
@nl
type
label
Progressive neurodegeneration ...... 1beta in the substantia nigra.
@en
Progressive neurodegeneration ...... 1beta in the substantia nigra.
@nl
prefLabel
Progressive neurodegeneration ...... 1beta in the substantia nigra.
@en
Progressive neurodegeneration ...... 1beta in the substantia nigra.
@nl
P2093
P1476
Progressive neurodegeneration ...... -1beta in the substantia nigra
@en
P2093
Carina Cintia Ferrari
Mariela Chertoff
María Clara Pott Godoy
Rodolfo Tarelli
P304
P356
10.1016/J.NBD.2006.06.013
P577
2006-08-09T00:00:00Z